H1B Report
Side-by-side comparison

SCIEGEN PHARMACEUTICALS, INC. vs WIPRO LIMITED

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
SCIEGEN PHARMACEUTICALS, INC.
NYRank #FEIN 30-0597093
Entity B
WIPRO LIMITED
NJRank #6FEIN 98-0154401

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricSCIEGEN PHARMACEUTICALS, INC.WIPRO LIMITED
Total filings35372,392▲
Certified %98.02%▲91.61%
Denied %0.57%0.37%▲
Withdrawn %1.13%1.37%
Cert-withdrawn %0.28%6.64%
Rank—#6
Active yearsFY2011–FY2026FY2010–FY2026
Worksite stateNYNJ

Outcomes — SCIEGEN PHARMACEUTICALS, INC.

DOL case-status mix.

Outcome breakdown: Certified 98.0%, Cert-withdrawn 0.3%, Withdrawn 1.1%, Denied 0.6%
Outcome breakdown
OutcomeShare
Certified98.0%
Cert-withdrawn0.3%
Withdrawn1.1%
Denied0.6%
Certified98.0%
Cert-withdrawn0.3%
Withdrawn1.1%
Denied0.6%

Outcomes — WIPRO LIMITED

DOL case-status mix.

Outcome breakdown: Certified 91.6%, Cert-withdrawn 6.6%, Withdrawn 1.4%, Denied 0.4%
Outcome breakdown
OutcomeShare
Certified91.6%
Cert-withdrawn6.6%
Withdrawn1.4%
Denied0.4%
Certified91.6%
Cert-withdrawn6.6%
Withdrawn1.4%
Denied0.4%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

SCIEGEN PHARMACEUTICALS, INC.
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20100
FY201129
FY20121
FY20131
FY201426
FY201528
FY201631
FY201747
FY201833
FY201942
FY20200
FY202118
FY20224
FY20232
FY202417
FY202535
FY202639
WIPRO LIMITED
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20103,039
FY20113,025
FY20127,031
FY20136,574
FY20148,104
FY201511,824
FY201610,254
FY20175,012
FY20186,067
FY20194,154
FY202094
FY2021128
FY202297
FY2023554
FY20242,296
FY20252,289
FY20261,850

Top 5 occupations — SCIEGEN PHARMACEUTICALS, INC.

Top 5 occupations — WIPRO LIMITED

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.
Swap A: SCIEGEN PHARMACEUTICALS, INC.
INFOSYS LIMITEDCOGNIZANT TECHNOLOGY SOLUTIONS US CORPTATA CONSULTANCY SERVICES LIMITEDDeloitte Consulting LLP
Swap B: WIPRO LIMITED
INFOSYS LIMITEDCOGNIZANT TECHNOLOGY SOLUTIONS US CORPTATA CONSULTANCY SERVICES LIMITEDDeloitte Consulting LLP
Or browse the full sponsor index.
SCIEGEN PHARMACEUTICALS, INC.WIPRO LIMITEDBrowse all